Zuckerberg-backed Biohub hires EvolutionaryScale team in apparent end of AI startupnews2025-11-07T00:06:20+00:00November 7th, 2025|Endpoints News|
Recursion CEO Chris Gibson to step down in 2026news2025-11-05T16:20:12+00:00November 5th, 2025|Endpoints News|
Nobel laureate David Baker on Nature paper for AI antibody modelnews2025-11-05T16:00:50+00:00November 5th, 2025|Endpoints News|
Research institute FutureHouse debuts AI scientist Kosmos and for-profit spinoffnews2025-11-05T12:00:33+00:00November 5th, 2025|Endpoints News|
Roche, Manifold Bio to advance new brain shuttles in pact worth up to $2B+news2025-11-03T11:45:30+00:00November 3rd, 2025|Endpoints News|
Eli Lilly, Nvidia say they’ll build pharma’s most powerful supercomputernews2025-10-28T18:30:18+00:00October 28th, 2025|Endpoints News|
Genesis Molecular AI claims its model Pearl beats AlphaFold 3news2025-10-28T18:30:15+00:00October 28th, 2025|Endpoints News|
Takeaways from Endpoints AI Day: Real progress, ‘stupid’ money and moonshotsnews2025-10-27T14:00:29+00:00October 27th, 2025|Endpoints News|
Tahoe Therapeutics releases virtual cell AI modelnews2025-10-23T11:00:43+00:00October 23rd, 2025|Endpoints News|
Amy Gleason, a top Trump health official, calls for more access to patient datanews2025-10-22T18:59:33+00:00October 22nd, 2025|Endpoints News|
